Plain-English translation of NCT07527923 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is a first-in-human study testing a new experimental medicine called . The study will involve healthy volunteers in Part A and people with atopic dermatitis (eczema) in Part B. Researchers want to understand how safe the medication is, what side effects it might cause, how the body processes it, and whether it helps improve eczema symptoms.
has never been tested in humans before. This trial is designed to find out whether this new treatment is safe and to determine the right dose that might help people with eczema in future studies.
You likely qualify if…
You likely don't qualify if…
In Part A, healthy volunteers will receive doses of the study medication or placebo (a fake treatment) and have blood tests and physical exams to check safety. In Part B, people with eczema will receive the medication or placebo and have their skin carefully evaluated before and after treatment. Both parts involve multiple clinic visits over several weeks to monitor for side effects, measure how much medication is in the blood, and assess whether the body develops antibodies against the treatment.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Belgium